Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Rohit David

Humiliation For Britain: US Pharma Giant Merck Axes £1 Billion London Lab, Brands UK 'Uninvestable'

US pharma giant Merck scraps £1B London research centre, branding UK ‘uninvestable’ due to NHS pricing and low investment (Credit: Merck website gallery photo)

In a devastating blow to Britain's life sciences ambitions, US pharmaceutical giant Merck has abandoned plans for its £1 billion ($1.53 billion) London research centre, branding the UK 'uninvestable' due to insufficient government support.

The decision, announced on 10 September 2025, will see 125 scientists and staff lose their jobs, raising alarm about the UK's declining competitiveness in global research. This move underscores mounting concerns over NHS drug pricing policies and underinvestment in innovation, threatening Britain's economic growth.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.